Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: A possible new immune intervention

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 5, 1999, Pages 507-510

  Bottari, Vincenzo ^a   Frezzolini, A ^b   Ruffelli, M ^b   Puddu, P ^b   Fontana, L ^c   De Pita O ^b  

^a SAN FILIPPO NERI HOSPITAL   (Italy)

^b LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Atopic dermatitis; Cyclosporin A; sCD30; Th2 immune response

Indexed keywords

BUDESONIDE; CD30 ANTIGEN; CYCLOSPORIN A; IMMUNOGLOBULIN E; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TOPICAL DRUG ADMINISTRATION;

ADULT; ANTIGENS, CD30; CYCLOSPORINE; DERMATITIS, ATOPIC; HUMANS; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-4; TH2 CELLS; TREATMENT OUTCOME;

EID: 0033022209     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00958.x     Document Type: Article

References (18)

1. Dupuy P. Pathophysiologic de la dermatité atopique. Nouv Dermatol 1995;14:243-245.
2. Leung DYM. Pathogenesis and clinical aspects of atopic dermatitis. Int J Immunopathol Pharmacol 1997;10:119.
3. Kägi MK, Joller-Jemelka H, Wüthrich B. Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 1992;185:88-92.
4. van der Heijden FL, Wierenga EA, Bos JD, Kapsenberg L. High frequency of IL-4 producing CD4+ allergen-specific T lymphocytes in atopic dermatitis lesional skin. J Invest Dermatol 1991;97:389-394.
5. Kägi MK, Wüthrich B, Montano E, et al. Differential cytokine profiles in peripheral blood lymphocyte supernatants and skin biopsies from patients with different forms of atopic dermatitis, psoriasis and normal individuals. Int Arch Allergy Immunol 1994;103:332-340.
6. Romagnani S, Del Prete G, Maggi E, et al. CD30 and type 2 helper (Th2) responses. J Leukoc Biol 1995;57:726-730.
7. Del Prete G, De Carli M, Almerigogna F, et al. Preferential expression of CD30 by human CD4+ T cells producing Th2-type cytokines. FASEB J 1995;9:81-86.
8. D'Elios MM, Romagnani P, Scaletti C, et al. In vivo CD30 expression in human disease with predominant activation of Th2-like T cells. J Leukoc Biol 1997;61:539-544.
9. Frezzolini A, Paradisi M, Ruffelli M, et al. Soluble CD30 in pediatric patients with atopic dermatitis. Allergy 1997;52:106-109.
10. Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized double-blind, placebo-controlled trial. Br J Dermatol 1993;129:422-430.
11. van Joost TH, Heule F, Korstanje M, et al. Cyclosporin in atopic dermatitis: a multicentre placebo-controlled study. Br J Dermatol 1994;130:634-640.
12. Berth-Jones J, Graham-Brown RAC, Marks R, et al. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol 1997;136:76-81.
13. van Joost T, Kozel MMA, Tank B, et al. Cyclosporine in atopic dermatitis. Modulation in the expression of immunologic markers in lesional skin. J Am Acad Dermatol 1992;27:922-928.
14. Andersson J, Nagy S, Groth CG, et al. Effect of FK506 and cyclosporin A on cytokine production studied in vitro at single cell level. Immunology 1992;75:136-142.
15. Dokter WH, Esselink MT, Sierdsema SJ, et al. Transcriptional and posttranscriptional regulation of interleukin-4 and interleukin-3 genes in human T cell. Blood 1993;81:35-40.
16. Campbell DE, Kemp AS. Cyclosporine restores cytokine imbalance in childhood atopic dermatitis. J Allergy Clin Immunol 1997;99:857-859.
17. Mori A, Suko M, Nishizaki Y, et al. Regulation of interleukin-5 production by peripheral blond mononuclear cells from atopic patients with FK506, cyclosporin A and glucocorticoid. Int Arch Allergy Immunol 1994;104:32-35.
18. Ishij E, Yamamoto S, Sakai R, et al. Production of interleukin-5 and the suppressive effect of cyclosporin A in childhood severe atopic dermatitis. J Pediatr 1996;128:152-155.